Antonino Amato

Antonino Amato

UNVERIFIED PROFILE

Are you Antonino Amato?   Register this Author

Register author
Antonino Amato

Antonino Amato

Publications by authors named "Antonino Amato"

Are you Antonino Amato?   Register this Author

20Publications

245Reads

28Profile Views

A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.

Vasc Med 2013 Feb 15;18(1):3-12. Epub 2013 Jan 15.

Harbor-UCLA Center for Clinical Pharmacology, Torrance, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1358863X12467491DOI Listing
February 2013

Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease.

J Cardiopulm Rehabil Prev 2011 Mar-Apr;31(2):125-32

University of Colorado School of Medicine, Division of Cardiology and CPC Clinical Research, Aurora, Colorado 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HCR.0b013e3181f1fd65DOI Listing
July 2011

Gender differences in locomotor and stereotypic behavior associated with l-carnitine treatment in mice.

Gend Med 2011 Feb;8(1):1-13

Sezione di Endocrinologia, Dipartimento Clinico Sperimentale di Medicina e Farmacologia, dell’Adolescenza e della Donna, Università di Messina, Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.genm.2011.02.003DOI Listing
February 2011

Elevated triglycerides correlate with progression of diabetic neuropathy.

Diabetes 2009 Jul 1;58(7):1634-40. Epub 2009 May 1.

Department of Neurology, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db08-1771DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699859PMC
July 2009

Phase I and pharmacokinetic study of gimatecan given orally once a week for 3 of 4 weeks in patients with advanced solid tumors.

Clin Cancer Res 2009 Jan;15(1):374-81

Massachusetts General Hospital, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1024DOI Listing
January 2009

Carnitine in metabolic disease: potential for pharmacological intervention.

Pharmacol Ther 2008 Nov 31;120(2):149-56. Epub 2008 Aug 31.

R&D Department, Iperboreal Pharma Srl, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2008.08.008DOI Listing
November 2008

Hemodynamic properties of a new-generation positive luso-inotropic agent for the acute treatment of advanced heart failure.

Am J Cardiol 2007 Jan 18;99(2A):41A-46A. Epub 2006 Sep 18.

Division of Cardiovascular Medicine, Department of Medicine, Henry Ford Health System, Detroit, Michigan 48202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2006.09.005DOI Listing
January 2007

Co-regulation of dopamine D1 receptor and uncoupling protein-2 expression in 3-nitropropionic acid-induced neurotoxicity: neuroprotective role of L-carnitine.

Neurosci Lett 2006 Dec 18;410(1):62-5. Epub 2006 Oct 18.

Division of Neurotoxicology, National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR 72079, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2006.09.070DOI Listing
December 2006

Effects of L-carnitine pretreatment in methamphetamine and 3-nitropropionic acid-induced neurotoxicity.

Ann N Y Acad Sci 2006 Aug;1074:74-83

Division of Neurotoxicology, HFT-132, FDA/NCTR, Jefferson, AR 72079-9502, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1369.006DOI Listing
August 2006

Identification of rat hippocampal mRNAs altered by the mitochondrial toxicant, 3-NPA.

Ann N Y Acad Sci 2005 Aug;1053:162-73

Division of Neurotoxicology, HFT-132, National Center for Toxicology Research, Food and Drug Administration, Jefferson, Arkansas 72079-9502, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1344.014DOI Listing
August 2005

Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials.

Diabetes Care 2005 Jan;28(1):89-94

Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/diacare.28.1.89DOI Listing
January 2005

Effects of carnitine on thyroid hormone action.

Ann N Y Acad Sci 2004 Nov;1033:158-67

Sezione di Endocrinologia, Dipartimento Clinico Sperimentale di Medicina e Farmacologia, University of Messina School of Medicine, 98125 Messina, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1196/annals.1320.015
Publisher Site
http://dx.doi.org/10.1196/annals.1320.015DOI Listing
November 2004

Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice.

J Biol Chem 2004 Oct 16;279(43):45155-61. Epub 2004 Aug 16.

Departments of Pharmacology and Therapeutics, Medical College of Ohio, Toledo, Ohio 43614, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M404764200DOI Listing
October 2004

Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease.

Kidney Int 2004 Feb;65(2):719-24

Harbor-UCLA Research and Education Institute, Torrance, CA 90502, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1523-1755.2004.00411.xDOI Listing
February 2004

Peripheral arterial disease is not associated with an increased prevalence of intradialytic cramps in patients on maintenance hemodialysis.

Am J Nephrol 2002 Sep-Dec;22(5-6):491-6

Department of Medicine, Harbor-UCLA Medical Center, Torrance, Calif. 90502, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000065285DOI Listing
March 2003

Clinical and demographic predictors of exercise capacity in end-stage renal disease.

Am J Kidney Dis 2002 Jan;39(1):76-85

Department of Medicine, Harbor-UCLA Research and Education Institute, Torrance, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/ajkd.2002.29884DOI Listing
January 2002